Publikasi · Scopus

Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer

Scopus Q1 2023

Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer

Advanced Pharmaceutical Bulletin

Cite as

(2023). Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer. <em>Advanced Pharmaceutical Bulletin</em>.

Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer

Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer

Akses Paper

Penulis Farmasi UMI

Cite as

Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer

Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer

Akses Paper

Penulis Farmasi UMI

Cite as

Publikasi Terkait

Synthesis and evaluation of radioiodinated 1-{2-[5-(2-methoxyethoxy)-1H-benzo[d]imidazol-1-yl]quinolin-8-yl}p…

Design, synthesis, and biological evaluation of radioiodinated benzo[d] imidazole-quinoline derivatives for p…

Development of Sun Screen Gel Formulation from Secang Wood Extract (Caesalpinia sappan L.)

Formulation of Mineral Salt and Milkfish Bone (Chanos chanos) Waste to Prevent Preeclampsia